Tag: graft-versus-host disease
Off-the-shelf immunotherapy could lead to more accessible cancer treatment
Immunotherapy is a type of cancer treatment that harnesses the immune system to destroy cancerous cells. Dr Li Zhang and colleagues at Toronto General Hospital Research Institute and the University of Toronto, are pioneering a new type of “off-the-shelf” treatment using a type of immune cell—a double negative T (DNT) cell. Dr Zhang‘s work shows that DNT cells are a […]
Read More… from Off-the-shelf immunotherapy could lead to more accessible cancer treatment